🚀 VC round data is live in beta, check it out!
Spok Valuation Multiples
Discover revenue and EBITDA valuation multiples for Spok and similar public comparables like Value HR, Nordhealth, Optima Health, MTI Ltd. and more.
Spok Overview
About Spok
Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.
Founded
2004
HQ
Employees
410
Website
Financials (LTM)
EV
$220M
Spok Financials
Spok reported last 12-month revenue of $140M and EBITDA of $29M.
In the same LTM period, Spok generated $109M in gross profit, $29M in EBITDA, and $15M in net income.
Revenue (LTM)
Spok P&L
In the most recent fiscal year, Spok reported revenue of $140M and EBITDA of $29M.
Spok expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $140M | XXX | $140M | XXX | XXX | XXX |
| Gross Profit | $109M | XXX | $110M | XXX | XXX | XXX |
| Gross Margin | 78% | XXX | 79% | XXX | XXX | XXX |
| EBITDA | $29M | XXX | $29M | XXX | XXX | XXX |
| EBITDA Margin | 21% | XXX | 21% | XXX | XXX | XXX |
| EBIT Margin | 14% | XXX | 14% | XXX | XXX | XXX |
| Net Profit | $15M | XXX | $16M | XXX | XXX | XXX |
| Net Margin | 11% | XXX | 11% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Spok Stock Performance
Spok has current market cap of $238M, and enterprise value of $220M.
Market Cap Evolution
Spok's stock price is $11.50.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $220M | $238M | 0.1% | XXX | XXX | XXX | $0.77 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSpok Valuation Multiples
Spok trades at 1.6x EV/Revenue multiple, and 7.6x EV/EBITDA.
EV / Revenue (LTM)
Spok Financial Valuation Multiples
As of April 20, 2026, Spok has market cap of $238M and EV of $220M.
Equity research analysts estimate Spok's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Spok has a P/E ratio of 15.6x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $238M | XXX | $238M | XXX | XXX | XXX |
| EV (current) | $220M | XXX | $220M | XXX | XXX | XXX |
| EV/Revenue | 1.6x | XXX | 1.6x | XXX | XXX | XXX |
| EV/EBITDA | 7.6x | XXX | 7.6x | XXX | XXX | XXX |
| EV/EBIT | 11.4x | XXX | 10.9x | XXX | XXX | XXX |
| EV/Gross Profit | 2.0x | XXX | 2.0x | XXX | XXX | XXX |
| P/E | 15.6x | XXX | 15.0x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 8.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Spok Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Spok Margins & Growth Rates
Spok's revenue in the last 12 month declined by (0%).
Spok's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.
Spok's rule of 40 is 20% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Spok's rule of X is 20% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Spok Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | (0%) | XXX | (0%) | XXX | XXX | XXX |
| EBITDA Margin | 21% | XXX | 21% | XXX | XXX | XXX |
| EBITDA Growth | (1%) | XXX | (1%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 20% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 20% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 12% | XXX | 13% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 24% | XXX | 24% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 9% | XXX | 9% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 64% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Spok Public Comps
See public comps and valuation multiples for other Healthcare Software comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Spok | XXX | XXX | XXX | XXX | XXX | XXX |
| Value HR | XXX | XXX | XXX | XXX | XXX | XXX |
| Nordhealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Optima Health | XXX | XXX | XXX | XXX | XXX | XXX |
| MTI Ltd. | XXX | XXX | XXX | XXX | XXX | XXX |
| Ascom | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Spok M&A Activity
Spok acquired XXX companies to date.
Last acquisition by Spok was on XXXXXXXX, XXXXX. Spok acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Spok
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialSpok Investment Activity
Spok invested in XXX companies to date.
Spok made its latest investment on XXXXXXXX, XXXXX. Spok invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Spok
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Spok
| When was Spok founded? | Spok was founded in 2004. |
| Where is Spok headquartered? | Spok is headquartered in United States. |
| How many employees does Spok have? | As of today, Spok has over 410 employees. |
| Who is the CEO of Spok? | Spok's CEO is Vincent D. Kelly. |
| Is Spok publicly listed? | Yes, Spok is a public company listed on Nasdaq. |
| What is the stock symbol of Spok? | Spok trades under SPOK ticker. |
| When did Spok go public? | Spok went public in 2004. |
| Who are competitors of Spok? | Spok main competitors are Value HR, Nordhealth, Optima Health, MTI Ltd.. |
| What is the current market cap of Spok? | Spok's current market cap is $238M. |
| What is the current revenue of Spok? | Spok's last 12 months revenue is $140M. |
| What is the current revenue growth of Spok? | Spok revenue growth (NTM/LTM) is (0%). |
| What is the current EV/Revenue multiple of Spok? | Current revenue multiple of Spok is 1.6x. |
| Is Spok profitable? | Yes, Spok is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Spok? | Spok's last 12 months EBITDA is $29M. |
| What is Spok's EBITDA margin? | Spok's last 12 months EBITDA margin is 21%. |
| What is the current EV/EBITDA multiple of Spok? | Current EBITDA multiple of Spok is 7.6x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.